StemCellAtlas

What is the Wolverine stack?

“Wolverine stack” is a reported name for BPC-157 plus TB-500. It identifies a pairing in peptide-stack descriptions, not a standardised treatment. The name alone does not specify the exact TB-500 substance, amount, route or product quality.

KLOW Clinic: stack naming · FDA: nominated peptide safety information

The two names on the list

Swipe or scroll sideways to compare all columns.

The two names on the list
ComponentWhat to distinguish
BPC-157Ingredient identity from claims made for the blend
TB-500The supplied molecule from the parent thymosin-beta-4 protein
WolverineA reported pair name; the name does not establish a validated protocol
KLOW Clinic: stack naming · FDA: nominated peptide safety information

Why the TB-500 detail matters

FDA’s safety note explicitly names thymosin beta-4 fragment LKKTETQ, also known as TB-500. A study using a parent protein, fragment or different preparation is not automatically a study of the vial sold under the same nickname. Match the substance before importing a result.

FDA: nominated peptide safety information

What the sources do and do not establish

The stack glossary is used here only to document the pairing name. It is not clinical evidence for recovery claims. FDA separately describes missing or limited safety information, possible immune reactions and peptide-related impurity concerns. Neither source supplies a dosing protocol for this combination.

KLOW Clinic: stack naming · FDA: nominated peptide safety information
An unlabelled amber vial and a glass dropper
Editorial still life; the containers do not identify a peptide or route of use.

Use the table and its sources

Download table CSV · Download table JSON · Dataset notes

Related reading

Source-linked editorial synthesis, prepared with AI assistance. This is not a clinician review or a personalised treatment recommendation. Corrections: editorial standards.